Literature DB >> 17287381

Psychotic disorders, eating habits, and physical activity: who is ready for lifestyle changes?

Suzanne M Archie1, Joel O Goldberg, Noori Akhtar-Danesh, Janet Landeen, Linda McColl, Jean McNiven.   

Abstract

OBJECTIVES: Significant weight gain is a serious side effect of many antipsychotic medications, yet successful strategies for significant weight loss are lacking. The transtheoretical model for weight management can be used to identify people who are ready to change (contemplation-preparation group) their eating habits and physical activity. This study compared characteristics of patients in Canada who had a psychotic disorder and were ready to make lifestyle changes with characteristics of patients who were not considering lifestyle changes.
METHODS: Participants were surveyed to determine their stages of change for eating habits and physical activity, and various characteristics were measured, including body mass index, body image, nutritional intake, and level of physical activity.
RESULTS: A total of 101 participants (64 men) (mean+/-SD age 35+/-11 years) were taking antipsychotic medications. Seventy-one percent had schizophrenia spectrum disorders, and 15% had affective psychosis. The prevalence of patients identified as being ready for change was higher than expected: 68% for eating habits and 54% for physical activity. Participants who were ready to change eating habits were also ready to change physical activity habits (p<.04). Stages of change for eating habits were associated with body mass index (p<.004), whereas stages of change for physical activity were associated with self-reported vigorous (p<.001) and moderate (p<.005) physical activity but not mild physical activity.
CONCLUSIONS: Clinicians may help patients develop healthier eating and physical activity habits by using the transtheoretical model, because it identifies patients who are ready to change to healthier lifestyle strategies and may help patients with antipsychotic-induced weight gain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287381     DOI: 10.1176/ps.2007.58.2.233

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  6 in total

1.  Mobility limitations in persons with psychotic disorder: findings from a population-based survey.

Authors:  Satu Viertiö; Päivi Sainio; Seppo Koskinen; Jonna Perälä; Samuli I Saarni; Marja Sihvonen; Jouko Lönnqvist; Jaana Suvisaari
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-09-17       Impact factor: 4.328

2.  Influence of Organized vs Non Organized Physical Activity on School Adaptation Behavior.

Authors:  Moşoi A Alexandru; Beckmann Jürgen; Mirifar Arash; Martinent Guillaume; Balint Lorand
Journal:  Front Psychol       Date:  2020-11-19

3.  Disordered Eating among People with Schizophrenia Spectrum Disorders: A Systematic Review.

Authors:  Anoop Sankaranarayanan; Karthika Johnson; Sanop J Mammen; Helen E Wilding; Deepali Vasani; Vijaya Murali; Deborah Mitchison; David J Castle; Phillipa Hay
Journal:  Nutrients       Date:  2021-10-27       Impact factor: 5.717

4.  Stages of changes for fruit and vegetable intake and their relation to the nutritional status of undergraduate students.

Authors:  Lígia Cardoso dos Reis; Ingrid Chaves Correia; Edna Shibuya Mizutani
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar

5.  A Randomized Controlled Trial on the Efficacy of a Psychosocial Behavioral Intervention to Improve the Lifestyle of Patients With Severe Mental Disorders: Study Protocol.

Authors:  Gaia Sampogna; Andrea Fiorillo; Mario Luciano; Valeria Del Vecchio; Luca Steardo; Benedetta Pocai; Marina Barone; Mario Amore; Francesca Pacitti; Liliana Dell'Osso; Giorgio Di Lorenzo; Mario Maj
Journal:  Front Psychiatry       Date:  2018-06-07       Impact factor: 4.157

6.  Barriers and facilitators of effective health education targeting people with mental illness: a theory-based ethnographic study.

Authors:  N F Hempler; R A S Pals; L Pedersbæk; P DeCosta
Journal:  BMC Psychiatry       Date:  2018-10-30       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.